References
- Vichinsky EP, Earles A, Johnson RA, et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990;322:1617–21.
- Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease: the Cooperative Study of Sickle Cell Disease. Blood 1990;76:1431–7.
- Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002;42:37–43.
- Castro O, Sandler SG, Houston-Yu P, Rana S. Predicting the effect of transfusing only phenotype matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002;42:684–90.
- Sakhalkar VS, Roberts K, Hawthorne LM, et al. Allosensitization in patients receiving multiple blood transfusions. Ann N Y Acad Sci 2005;1054:495–9.
- Lasalle-Williams M, Nuss R, Le T, et al. Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME). Transfusion 2011;51:1732–9.
- Miller ST, Kim HY, Weiner DL, et al. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010. Transfusion 2013;53:704–9.
- Telen MJ, Afenyi-Annan A, Garrett ME, et al. Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival. Transfusion 2015;55:1378–87.
- Vichinsky EP, Luban NL, Wright E, et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001;41:1086–92.
- Tahhan HR, Holbrook CT, Braddy LR, et al. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion 1994;34:562–69.
- Cox JV, Steane E, Cunningham G, Frenkel EP. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Arch Intern Med 1988;148:2485–9.
- Talano JA, Hillery CA, Gottschall JL, et al. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics 2003;111:e661–5.
- Vidler JB, Gardner K, Amenyah K, et al. Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience. Br J Haematol 2015;169:746–53.
- Nickle RS, Hendrickson JE, Fasano RM, et al. Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series. Transfusion 2016;56:107–14.
- Chou ST, Jackson T, Vege S, et al. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 2013;122:1062–71.
- Casas J, Friedman DF, Jackson T, et al. Changing practice: red blood cell typing by molecular methods for patients with sickle cell disease. Transfusion 2015;55:1388–93.
- Anstee D. Red cell genotyping and the future of pretransfusion testing. Blood 2009;114:248–56.
- Sapatnekar S, Figueroa PI. How do we use molecular red blood cell antigen typing to supplement pretransfusion testing? Transfusion 2014;54:1452–8.
- Meyer S, Vollmert C, Trost N, et al. High-throughput Kell, Kidd, and Duffy matrix-assisted laser desorption/ionization, time-of-flight mass spectrometry–based blood group genotyping of 4000 donors shows close to full concordance with serotyping and detects new alleles. Transfusion 2014;54:3198–207.
- Kappler-Gratias S, Peyrard T, Beolet M, et al. Blood group genotyping by high-throughput DNA analysis applied to 356 reagent red blood cell samples. Transfusion 2011;51:36–42.
- Montpetit A, Phillips MS, Mongrain I, et al. High-throughput molecular profiling of blood donors for minor red blood cell and platelet antigens. Transfusion 2006;46:841–8.
- International Society of Blood Transfusion (ISBT). http://www.isbtweb.org/fileadmin/user_upload/ISBT004-RHCE15th_July_2019.pdf. Accessed July 2020.
- Reid M, Lomas-Francis C, Olsson ML. The blood group antigens factsbook. 3rd ed. London: Academic Press, 2012.
- Wilkinson K, Harris S, Gaur P, et al. Molecular blood typing augments serologic testing and allows for enhanced matching of red blood cells for transfusion in patients with sickle cell disease. Transfusion 2012;52:381–8.
- López M, Apraiz I, Rubia M, et al. Performance evaluation study of ID CORE XT, a high throughput blood group genotyping platform. Blood Transfus 2018;16:193–9.